Comparative Bioavailability in Healthy Elderly Volunteers

Summary

A randomised four way crossover design in which each subject will receive two dose levels of TRx-0037 and two doses of TRx-0014 over approximately a four week period in randomised order.

Timeline

Start

2010-02

Primary completion

2010-04

Completion

2010-04

Drugs

Indications